Active	Status	Sponsor type	Region	Phase	Filter
3 Active 5 Inactive 8 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

3 Trials

Active Trials   Industry lead sponsorIndustry collaborator

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
Kozuma, Ken
ASET-JAPAN, NCT05117866: Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study	Active, not recruiting	N/A	307	Europe, Japan	prasugrel Monotherapy, PCI with the SYNERGY® stent	Meditrix Corp, Fujita Health University, Boston Scientific Japan K.K., National University of Ireland, Galway, Ireland	Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome	07/24	12/25
Nagase, Hiroyuki
NIMBLE, NCT04718389 / 2020-003612-28: A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype Feb 2024 - Jun 2024 : Acceptance of regulatory submission in China for CRSwNP	Active, not recruiting	3	1667	Europe, Canada, Japan, US, RoW	GSK3511294 (Depemokimab), Mepolizumab, Benralizumab, Placebo, Standard of care (SoC), Pre-filled Syringes (PFS)	GlaxoSmithKline, Iqvia Pty Ltd	Asthma	10/25	10/25
Kawashima, Hideyuki
ASET-JAPAN, NCT05117866: Acetyl Salicylic Elimination Trial JAPAN: The ASET JAPAN Pilot Study	Active, not recruiting	N/A	307	Europe, Japan	prasugrel Monotherapy, PCI with the SYNERGY® stent	Meditrix Corp, Fujita Health University, Boston Scientific Japan K.K., National University of Ireland, Galway, Ireland	Chronic Coronary Syndrome, Non ST Segment Elevation Acute Coronary Syndrome	07/24	12/25